Kelkar 2021.

Study characteristics
Methods	Study design: cohort study  Type of publication: journal publication Setting and dates: webinar, January 2021 Country: USA Language: English
Interventions	Educational webinar “Cancer in the Time of Coronavirus: COVID‐19 Vaccine.”  Framing of survey questions: positive framing (90% effective rate), negative framing (10% failure rate), frequency (preventing 9 out of 10 people being infected)
Population	Population: cancer patients and caregivers Age; mean (SD): NR Gender: 20% Male, 79% Female, 0.5% Non‐binary, 2 % prefer not to answer Ethnicity: 1% American Indian, 5% Asian, 6% Black, 0.5% Hawaiian, 82% White, Other 3%, prefer not to answer 3% Number of participants (recruited/allocated/evaluated): 364 participated in webinar, 105 people completed both surveys Inclusion/exclusion criteria: NR
Outcomes	Intention change to receive a COVID‐19 vaccine after the webinar measured on a survey  Changes in beliefs and perceptions on the COVID‐19 vaccine Willingness to receive a vaccine with a 90% or 10% effectiveness or protecting 9 out of 10 people
Notes	Funding: no external funding reported COI: none declared